The role of viruses in etiopathogenesis of non-Hodgkin lymphomas

被引:0
|
作者
Dobrzanska, Joanna [1 ]
Sawczuk-Chabin, Joanna [1 ]
Warzocha, Krzysztof [1 ]
机构
[1] Inst Hematol & Transfuzjol Warszawie, Klin Hematol, Ul Chocimska 5, PL-00957 Warsaw, Poland
来源
ONCOLOGY IN CLINICAL PRACTICE | 2006年 / 2卷 / 02期
关键词
lymphoma; etiopathogenesis; viruses;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present article is a summary of current knowledge on mechanisms of viral etiopathogenesis in non-Hodgkin lymphomas (NHL). Some data has proved an oncogenic significance of Epstein-Barr (EBV) and human T-cell leukemia/lymphoma virus type I (HTLV-I). In case of others, including human immunodeficiency virus (HIV-1 and HIV-2), hepatitis type C (HCV), cytomegalovirus (CMV), human herpesvirus type 8 (HHV-8), SV-40 or HTLV-II, there are some evidences suggesting their participation in the development of NHL, however their real role in this phenomenon has not been proved so far. Scientific insights into ethiopathogenesis of NHL provide not only theoretical value but also important diagnostic and therapeutic implications in this group of malignancies.
引用
收藏
页码:64 / 72
页数:9
相关论文
共 50 条
  • [21] Non-Hodgkin lymphomas in pregnancy: Tackling therapeutic quandaries
    Avivi, Irit
    Farbstein, Dan
    Brenner, Benjamin
    Horowitz, Netanel A.
    BLOOD REVIEWS, 2014, 28 (05) : 213 - 220
  • [22] Changing incidence of non-Hodgkin lymphomas in the United States
    Clarke, CA
    Glaser, SL
    CANCER, 2002, 94 (07) : 2015 - 2023
  • [23] HCV infection and non-Hodgkin lymphomas: an evolving story
    Defrancesco, Irene
    Zerbi, Caterina
    Rattotti, Sara
    Merli, Michele
    Bruno, Raffaele
    Paulli, Marco
    Arcaini, Luca
    CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 20 (03) : 321 - 328
  • [24] Incidence and outcomes of rare paediatric non-hodgkin lymphomas
    Sorge, Caryn
    Costa, Luciano J.
    Taub, Jeffrey W.
    Cairo, Mitchell S.
    Xavier, Ana C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (05) : 864 - 867
  • [25] The management of adult aggressive non-Hodgkin's lymphomas
    Couderc, B
    Dujols, JP
    Mokhtari, F
    Norkowski, JL
    Slawinski, JC
    Schlaifer, D
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2000, 35 (01) : 33 - 48
  • [26] Major histocompatibility complex abnormalities in non-Hodgkin lymphomas
    Drénou, B
    Le Friec, G
    Bernard, M
    Pangault, C
    Grosset, JM
    Lamy, T
    Fauchet, R
    Amiot, L
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 119 (02) : 417 - 424
  • [27] HCV infection and non-Hodgkin lymphomas: an evolving story
    Irene Defrancesco
    Caterina Zerbi
    Sara Rattotti
    Michele Merli
    Raffaele Bruno
    Marco Paulli
    Luca Arcaini
    Clinical and Experimental Medicine, 2020, 20 : 321 - 328
  • [28] The emerging role of Bortezomib in the treatment of indolent non-Hodgkin's and mantle cell lymphomas
    O'Connor O.A.
    Current Treatment Options in Oncology, 2004, 5 (4) : 269 - 281
  • [29] Adhesion molecules in the dissemination of non-Hodgkin's lymphomas
    Pals, ST
    Drillenburg, P
    Radaszkiewicz, T
    MantenHorst, E
    ACTA HAEMATOLOGICA, 1997, 97 (1-2) : 73 - 80
  • [30] Nm23-H1 expression in non-Hodgkin and Hodgkin lymphomas
    Bircan, Sema
    Inamdar, Kedar V.
    Rassidakis, George Z.
    Medeiros, L. J.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2008, 16 (03): : 207 - 214